1. MEDICINES FOR PEOPLE PACKAGED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -150UP ASPARKAM TABLETS. ?50 -5000UP XANTHINOL NICOTINE
1. MEDICINES FOR PEOPLE PACKAGED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -150UP ASPARKAM TABLETS. ?50 -5000UP XANTHINOL NICOTINE
1. MEDICINES FOR PEOPLE PACKAGED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -120UP BRAND: HALYCHPHARM COUNTRY OF MANUFACTURE
1. MEDICINES FOR PEOPLE PACKAGED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -120UP BRAND: HALYCHPHARM COUNTRY OF MANUFACTURE
04-February-2019
3004900000
1. MEDICINES FOR HUMANS FORMULATED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -10 PACK. ASPARKAM DISTRICT D / IN. AMP. 5 ML ?10 -60 PACK. ASPARKAM TABLE. ?50
1. MEDICINES FOR HUMANS FORMULATED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 0.1% AMP. 5 ML ?10 -10 PACK. ASPARKAM DISTRICT D / IN. AMP. 5 ML ?10 -60 PACK. ASPARKAM TABLE. ?50
04-February-2019
3004900000
1. MEDICINES FOR HUMANS FORMULATED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 1 MG / ML AMP. 5 ML BLISTER IN A PACK ? 10 -150UP. THIOTRIAZOLINE DISTRICT D / IN. 25 MG / M 2
1. MEDICINES FOR HUMANS FORMULATED FOR RETAIL TRADE CONSISTING OF UNMIXED PRODUCTS FOR THERAPEUTIC USE IN DOSAGE FORM: L-LYSINE ESCINATE RN D / IN. 1 MG / ML AMP. 5 ML BLISTER IN A PACK ? 10 -150UP. THIOTRIAZOLINE DISTRICT D / IN. 25 MG / M 2
13-November-2019
3004900000
1. MEDICINES IN FINISHED FORMS PACKAGED FOR RETAIL SALE FOR THE TREATMENT SPETSYFICHNYHNEDUH OR ILLNESS NOT CONTAINING NARCOTIC DRUGS PSYCHOTROPIC SUBSTANCES AND PRECURSORS NOT IN AEROSOL PACKAGING: L-LYSINE ESCUNAT INJECTION
1. MEDICINES IN FINISHED FORMS PACKAGED FOR RETAIL SALE FOR THE TREATMENT SPETSYFICHNYHNEDUH OR ILLNESS NOT CONTAINING NARCOTIC DRUGS PSYCHOTROPIC SUBSTANCES AND PRECURSORS NOT IN AEROSOL PACKAGING: L-LYSINE ESCUNAT INJECTION